Barclays PLC Inspire Medical Systems, Inc. Transaction History

Barclays PLC

$436 Billion
Q2 2025

A detailed history of Barclays PLC transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Barclays PLC holds 11,993 shares of INSP stock, worth $969,034. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,993

Previous 11,993 -0.0%

Holding current value

$969,034

Previous $1.56 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$127.18 - $161.88 $2.12 Million - $2.7 Million	-16,693 Reduced 58.19%	11,993 $1.56 Million
Q1 2025 May 15, 2025	BUY	$157.24 - $215.42 $48,901 - $66,995	311 Added 1.1%	28,686 $4.57 Million
Q4 2024 Feb 13, 2025	SELL	$172.7 - $214.93 $2.44 Million - $3.04 Million	-14,150 Reduced 33.27%	28,375 $5.26 Million
Q3 2024 Nov 15, 2024	SELL	$125.79 - $216.71 $5.62 Million - $9.68 Million	-44,680 Reduced 51.24%	42,525 $8.98 Million
Q2 2024 Aug 14, 2024	BUY	$133.83 - $251.19 $8.99 Million - $16.9 Million	67,206 Added 336.05%	87,205 $11.7 Million
Q1 2024 May 15, 2024	SELL	$165.3 - $226.0 $8.96 Million - $12.2 Million	-54,192 Reduced 73.04%	19,999 $4.3 Million
Q4 2023 Feb 15, 2024	SELL	$125.26 - $203.83 $719,618 - $1.17 Million	-5,745 Reduced 7.19%	74,191 $15.1 Million
Q3 2023 Nov 07, 2023	BUY	$185.0 - $326.08 $7.4 Million - $13 Million	39,988 Added 100.1%	79,936 $15.9 Million
Q2 2023 Aug 03, 2023	BUY	$226.52 - $324.64 $2.29 Million - $3.27 Million	10,088 Added 33.78%	39,948 $13 Million
Q1 2023 May 04, 2023	BUY	$229.06 - $278.01 $4.52 Million - $5.48 Million	19,729 Added 194.74%	29,860 $6.99 Million
Q4 2022 Feb 13, 2023	BUY	$164.02 - $259.76 $1.46 Million - $2.31 Million	8,896 Added 720.32%	10,131 $2.55 Million
Q3 2022 Nov 03, 2022	SELL	$170.68 - $226.46 $28,844 - $38,271	-169 Reduced 12.04%	1,235 $219,000
Q2 2022 Aug 12, 2022	SELL	$147.53 - $266.6 $610,036 - $1.1 Million	-4,135 Reduced 74.65%	1,404 $256,000
Q1 2022 May 16, 2022	SELL	$193.94 - $261.91 $5.47 Million - $7.39 Million	-28,207 Reduced 83.59%	5,539 $1.42 Million
Q4 2021 Feb 14, 2022	BUY	$207.57 - $280.17 $3.96 Million - $5.35 Million	19,090 Added 130.25%	33,746 $7.76 Million
Q3 2021 Nov 09, 2021	BUY	$170.0 - $258.58 $1.45 Million - $2.2 Million	8,517 Added 138.74%	14,656 $3.41 Million
Q2 2021 Aug 13, 2021	SELL	$164.93 - $242.23 $3.23 Million - $4.75 Million	-19,603 Reduced 76.15%	6,139 $1.19 Million
Q1 2021 May 13, 2021	BUY	$182.45 - $249.25 $2.85 Million - $3.89 Million	15,616 Added 154.22%	25,742 $5.33 Million
Q4 2020 Feb 11, 2021	SELL	$119.35 - $200.46 $222,826 - $374,258	-1,867 Reduced 15.57%	10,126 $1.9 Million
Q3 2020 Nov 12, 2020	SELL	$87.5 - $130.91 $273,875 - $409,748	-3,130 Reduced 20.7%	11,993 $1.55 Million
Q2 2020 Aug 12, 2020	SELL	$49.5 - $97.93 $1.21 Million - $2.39 Million	-24,407 Reduced 61.74%	15,123 $1.32 Million
Q1 2020 May 13, 2020	SELL	$41.62 - $89.92 $2.54 Million - $5.5 Million	-61,129 Reduced 60.73%	39,530 $2.38 Million
Q4 2019 Feb 10, 2020	BUY	$52.12 - $75.0 $1.32 Million - $1.91 Million	25,421 Added 33.79%	100,659 $7.47 Million
Q3 2019 Nov 14, 2019	BUY	$61.02 - $70.19 $666,460 - $766,615	10,922 Added 16.98%	75,238 $4.59 Million
Q2 2019 Aug 14, 2019	BUY	$47.07 - $60.71 $2.83 Million - $3.65 Million	60,075 Added 1416.53%	64,316 $3.9 Million
Q1 2019 May 15, 2019	SELL	$39.48 - $62.0 $1.62 Million - $2.54 Million	-40,918 Reduced 90.61%	4,241 $241,000
Q4 2018 Feb 14, 2019	BUY	$37.07 - $52.58 $1.45 Million - $2.06 Million	39,229 Added 661.53%	45,159 $1.91 Million
Q3 2018 Nov 14, 2018	BUY	$36.8 - $56.99 $197,063 - $305,181	5,355 Added 931.3%	5,930 $250,000
Q2 2018 Aug 14, 2018	BUY	$24.05 - $39.5 $13,828 - $22,712	575 New	575 $21,000

Others Institutions Holding INSP

# of Institutions

393

Shares Held

29.5M

Call Options Held

117K

Put Options Held

148K

View Full List

About Inspire Medical Systems, Inc.

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $2.33B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

More about INSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account